Skip to main content
. 2022 Oct 14;14(10):2189. doi: 10.3390/pharmaceutics14102189

Figure 2.

Figure 2

Effects of exosomes on proliferation and osteogenic differentiation of BMSCs (A) Ingestion of exosomes by BMSCs (B) ALP staining after 14 days of osteogenic induction (C) CCK-8 assay results; Asterisk (*), p < 0.05 compared to the control group; pound sign (#), p < 0.05 compared to the exosome 10 μg/mL group.